Dihydropyrrolopyrazole transforming growth factor-beta type I receptor kinase domain inhibitors: a novel benzimidazole series with selectivity versus transforming growth factor-beta type II receptor kinase and mixed lineage kinase-7. (Q53632406)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Dihydropyrrolopyrazole transforming growth factor-beta type I receptor kinase domain inhibitors: a novel benzimidazole series with selectivity versus transforming growth factor-beta type II receptor kinase and mixed lineage kinase-7. |
scientific article |
Statements
Dihydropyrrolopyrazole transforming growth factor-beta type I receptor kinase domain inhibitors: a novel benzimidazole series with selectivity versus transforming growth factor-beta type II receptor kinase and mixed lineage kinase-7. (English)
Hong-yu Li
Yan Wang
Charles R Heap
Chi-Hsin R King
Sreenivasa R Mundla
Matthew Voss
David K Clawson
Lei Yan
Robert M Campbell
Bryan D Anderson
Jill R Wagner
Karen Britt
Ku X Lu
William T McMillen
Jonathan M Yingling
1 March 2006
49
6
2138-2142